Citations:
1982Science (Jan. 29) “Harvard Delays in Reporting Fraud” p. vol. 215, no. 4532, p. 480: Late in September 1981, the Harvard team sent its portion of the AMPIM data to the NIGH in preparation for a group meeting in Bethesda at which the participants would, for the first time, discuss unblinded results. 1988Medical World News (Feb. 8) p. vol. 29, no. 3, p. 76: I know you’re on the research end of things, not economic policy, but if at two years you unblind the study and the drug is having a positive effect, at some point those patients will have to start paying for it themselves, and at current prices it would be prohibitively expensive for many. 2004Izzle Pfaff (Apr. 22) “Dreamlike Occurrences That Were Not Actually Dreams”: When a patient is on a double-blind study, there are certain times when the doctor needs to “unblind” them, which is just revealing whatever crap the patient was getting: drug or placebo, etc.